Elevated Concentration of Interferon-Inducible Protein of 10 kD (IP-10) is Associated with Coronary Atherosclerosis

International Heart Journal

Volumn 56, Issue 3, 2015, Pages 269-272

  Niki, Toshiyuki ^a,b   Soeki, Takeshi ^a   Yamaguchi, Koji ^a   Taketani, Yoshio ^b   Yagi, Shusuke ^a   Iwase, Takashi ^a   Yamada, Hirotsugu ^a   Wakatsuki, Tetsuzo ^a   Shimabukuro, Michio ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b SHIKOKU MEDICAL CENTER FOR CHILDREN AND ADULTS   (Japan)

Author keywords

Chemokine; Coronary artery disease; Coronary circulation

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; ADENYL-5'-O-PHOSPHOROTHIOATE-(3'-5')ADENOSINE; BIOLOGICAL MARKER; DINUCLEOSIDE PHOSPHATE; NUCLEOTIDE; RANTES;

AGED; ANGIOCARDIOGRAPHY; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY SINUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI SCORE; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; BLOOD; CORONARY ARTERY DISEASE; PHYSIOLOGY; RADIOGRAPHY; SECRETION (PROCESS);

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CXCL10; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DINUCLEOSIDE PHOSPHATES; FEMALE; HUMANS; MALE; T-LYMPHOCYTES; THIONUCLEOTIDES;

EID: 84929256682     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-300     Document Type: Article

References (21)

1. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74. (Review)
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95. (Review)
3. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001; 104: 503-16. (Review)
4. Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 1997-2008. (Review)
5. Mach F, Sauty A, Iarossi AS, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheromaassociated cells. J Clin Invest 1999; 104: 1041-50.
6. Veillard NR, Steffens S, Pelli G, et al. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 2005; 112: 870-8.
7. Heller EA, Liu E, Tager AM, et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 2006; 113: 2301-12.
8. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-7.
9. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88: 5252-6.
10. von Hundelshausen P, Weber KS, Huo Y, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-7.
11. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
12. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
13. Okamoto Y, Folco EJ, Minami M, et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res 2008; 102: 218-25.
14. Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem 1996; 271: 24286-93.
15. Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006; 26: 194-9.
16. Kajitani N, Shikata K, Nakamura A, Nakatou T, Hiramatsu M, Makino H. Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2010; 88: 171-6.
17. Zuojun H, Lingyu H, Wei H, et al. Interference of IP-10 expression inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in carotid artery: a new insight in the prevention of restenosis. Cell Biochem Biophys 2012; 62: 125-35.
18. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6: 21-9. (Review)
19. Mazzone A, De Servi S, Mazzucchelli I, et al. Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T. Heart 2001; 85: 571-5.
20. Potteaux S, Combadière C, Esposito B, et al. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2006; 26: 1858-63.
21. Kuziel WA, Dawson TC, Quinones M, et al. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 2003; 167: 25-32.